Torchmark Corporation Form 10-Q Summary
Entity and period: The supplied filing is Torchmark Corporation’s unaudited Form 10-Q for the quarter and six months ended June 30, 2015, filed August 7, 2015. Although the request identifies Globe Life Inc., the registrant named in this filing is Torchmark Corporation.
Financial results
| Metric | Q2 2015 | Q2 2014 | Six months 2015 | Six months 2014 |
|---|---|---|---|---|
| Total revenue | $1,033.7 million | $991.0 million | $2,056.2 million | $2,015.2 million |
| Net income | $127.1 million | $130.9 million | $248.8 million | $263.8 million |
| Diluted EPS | $1.00 | $0.98 | $1.94 | $1.97 |
- For the first six months, premium revenue was $1,665.7 million, up about 3% year over year. Life premium grew 5%; health premium reported under GAAP declined 1%, partly reflecting lower Medicare Part D premiums.
- Six-month pretax income fell about 6% to $368.8 million. Net income fell about 6%, while diluted EPS declined about 2%, supported by fewer shares outstanding.
- Six-month life underwriting income was $280.8 million, approximately flat, but the margin declined to 27% of premium from 29%. Health underwriting income rose to $103.2 million from $99.2 million, with margin down to 22% from 23%. Medicare Part D underwriting income fell 41% to $10.7 million, and its margin declined to 7% from 11%.
- Net investment income rose 2% to $386.4 million for the six months. Excess investment income was $112.2 million, down 2%; excess investment income per diluted share increased 4% to $0.88.
- Operating cash flow was $454.1 million, versus $419.4 million. Investing activities used $356.6 million and financing activities used $106.2 million. Cash ended the period at $62.8 million; cash plus short-term investments totaled about $91.5 million.
- At June 30, total assets were $20.0 billion and shareholders’ equity was $4.3 billion. Short-term debt was $636.9 million and long-term debt was $743.3 million. Commercial paper outstanding was $387.5 million. The $750 million credit facility had $164.5 million available after letters of credit.
Changes and notable items
- Six-month net income declined despite higher revenue, reflecting higher benefits and acquisition costs, lower realized investment gains, and a larger Medicare Part D interim-period adjustment. The prior-year period included $11.2 million of after-tax realized investment gains, compared with $1.8 million in 2015.
- Net unrealized gains on fixed maturities fell to about $995 million from $1.7 billion at year-end 2014 as market interest rates rose. After-tax other comprehensive loss was $442.1 million for the six months; shareholders’ equity declined from $4.7 billion at year-end, also affected by share repurchases.
- The company repurchased 3.85 million shares for $211.6 million during the six months, including purchases funded by option exercise proceeds. The board reaffirmed the ongoing repurchase program in August; it has no stated maximum authorization.
- Adoption of new affordable-housing investment accounting guidance reclassified certain amortization from investment income to income tax expense in comparative periods, with no effect on net income or cash flows.
Outlook, commentary, and risks
- Management reported growth in life sales and premium, highlighting stronger American Income agency production. It attributed lower life margins to higher-than-expected Globe Life Direct Response policy obligations and increased channel-support costs; mortality improvement on certain newer policies has been less than expected.
- Management expected the 2015 Medicare Part D benefit ratio to be approximately 85%, versus 83% for 2014. It stated that segment-versus-GAAP interim reporting differences should disappear by year-end. Part D results remain exposed to drug utilization, claim costs, and government program changes.
- Management expected Medicare-related claim funding and rebate timing delays to reduce net investment income by about $4 million over the remainder of 2015, following an estimated $2 million reduction in the first six months. New fixed-maturity investments yielded 4.59%, below the prior-year 5.00%; management noted continued pressure from low reinvestment yields.
- Management said it expected to have adequate liquidity from operating cash flows, subsidiary dividends, and credit availability. The insurance subsidiaries’ RBC ratio was 327% at December 31, 2014, against a stated target of about 325%; a June 30, 2015 RBC ratio is not provided in the filing text.
- Risks identified include interest-rate and credit changes, insurance mortality and morbidity experience, policy lapse rates, competition, regulatory changes affecting Medicare and health premium rates, litigation, and execution of marketing initiatives. Management reported no material change in risk factors or market-risk exposure.
- Unclaimed-property audits involving 47 states had produced no financial assessment; the company said a loss range could not be estimated. A putative class action concerning premiums on lapsed policies was pending, and the court had not ruled on the company’s motion to dismiss. Management did not believe litigation overall would materially affect financial condition, results, or liquidity, while acknowledging potentially unpredictable punitive judgments.
Investor verification priorities
- Confirm the issuer identity and whether Torchmark Corporation is the intended entity for this request.
- Review the drivers of weaker life and Part D underwriting margins, including Direct Response claims experience and Part D drug costs.
- Assess the fixed-maturity portfolio’s interest-rate sensitivity, unrealized losses, credit quality, and below-investment-grade exposure.
- Check short-term borrowing, remaining credit-facility availability, and the upcoming $292.7 million senior-note maturity in June 2016.
- Monitor cash generation, repurchases, subsidiary dividend capacity, and the insurance subsidiaries’ RBC position.
- Track the unclaimed-property audits and the lapsed-policy class action, for which the filing provides no quantified loss estimate.